IRVINE, Calif. (AP) _ Axonics Modulation Technologies Inc. (AXNX) on Thursday reported a loss of $15.2 million in its fourth quarter.On a per-share basis, the Irvine, California-based company said it had a loss of 34 cents.The results beat Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 36 cents per share.The medical technology company posted revenue of $53.1 million in the period, also surpassing Street forecasts. Four analysts surveyed by Zacks expected $49.8 million.For the year, the company reported that its loss widened to $80.1 million, or $1.86 per share. Revenue was reported as $180.3 million.Axonics expects full-year revenue of $234 million.Axonics shares have fallen almost 6% since the beginning of the year. In the final minutes of trading on Thursday, shares hit $52.89, climbing slightly in the last 12 months.ADVERTISEMENT_____This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AXNX at https://www.zacks.com/ap/AXNX